Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06467786 | Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer | recruiting | Phase 4 | 24 | Tang-Du HospitalOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05701241 | Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients(SAUNA) | recruiting | Phase 4 | 270 | University Hospital, AntwerpOTHER | 2 | Jun 14, 2024 | clinicaltrials |
| NCT03927391 | Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects(REDOSE) | completed | Phase 4 | 57 | Radboud University Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05078671 | Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness(PROACTIVE) | unknown | Phase 4 | 160 | Radboud University Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05518929 | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients(SpO2) | completed | Phase 4 | 1,090 | RenJi HospitalOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT06428682 | Role of TXA in Patients Undergoing Breast Free Flap Reconstruction | unknown | Phase 4 | 100 | University of VirginiaOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT04641819 | Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients | unknown | Phase 4 | 1,127 | ShuGuang HospitalOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT06425276 | Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation | completed | Phase 4 | 67 | CASI Pharmaceuticals (China) Co., Ltd.INDUSTRY | 1 | May 23, 2024 | clinicaltrials |
| NCT06417606 | Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 20 | Zhiyong HuangOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT03301857 | Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 | completed | Phase 4 | 85 | AmgenINDUSTRY | 8 | May 20, 2024 | clinicaltrials |
| NCT04562428 | The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial | completed | Phase 4 | 10 | China Medical University HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06410833 | Belimumab After Rituximab in Resistant Primary Juvenile SS(BRRPJS) | recruiting | Phase 4 | 15 | Peking Union Medical College HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05957822 | Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | unknown | Phase 4 | 148 | Konkuk University Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05525338 | Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels(ADAPT ALEC) | recruiting | Phase 4 | 196 | University Medical Center GroningenOTHER | 2 | May 13, 2024 | clinicaltrials |
| NCT03712969 | Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC | completed | Phase 4 | 527 | West China HospitalOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06406127 | Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients | unknown | Phase 4 | 92 | Ain Shams UniversityOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06398028 | The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound. | recruiting | Phase 4 | 173 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT05354856 | The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer. | terminated | Phase 4 | 11 | Rigshospitalet, DenmarkOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT05054998 | Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases | completed | Phase 4 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT06388135 | Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma | not yet recruiting | Phase 4 | 80 | Yang Jianjun, PhDOTHER | 0 | Apr 29, 2024 | clinicaltrials |
| NCT06116461 | Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response(NIVOPTIMIZE) | unknown | Phase 4 | 34 | Erasmus Medical CenterOTHER | 1 | Apr 22, 2024 | clinicaltrials |
| NCT01641172 | Taste, Smell and Chemotherapy (TASTY)(TASTY) | completed | Phase 4 | 140 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT00942968 | Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer | completed | Phase 4 | 338 | PfizerINDUSTRY | 5 | Apr 18, 2024 | clinicaltrials |
| NCT05661357 | Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression(HCCSC-C03) | unknown | Phase 4 | 51 | Zhongnan HospitalOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT00733538 | Stage I Multiple Myeloma Treatment(IFM-01-04) | completed | Phase 4 | 89 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06357598 | Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer(PILOT) | unknown | Phase 4 | 30 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT04511533 | Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations | completed | Phase 4 | 101 | PfizerINDUSTRY | 1 | Apr 5, 2024 | clinicaltrials |
| NCT05070754 | Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca | completed | Phase 4 | 17 | Medical University of South CarolinaOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03817853 | An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma | completed | Phase 4 | 114 | Hoffmann-La RocheINDUSTRY | 7 | Apr 4, 2024 | clinicaltrials |
| NCT06049693 | Iron Prehabilitation in Endometrial Cancer(IROGYN) | completed | Phase 4 | 156 | National and Kapodistrian University of AthensOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT04574947 | Lidocaine And Neuromonitoring in Thyroid Surgery | completed | Phase 4 | 110 | Saint Petersburg State University, RussiaOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06316908 | Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach | completed | Phase 4 | 30 | Sindh Institute of Urology and TransplantationOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03629886 | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | completed | Phase 4 | 6,051 | GlaxoSmithKlineINDUSTRY | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06311916 | Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model. | not yet recruiting | Phase 4 | 312 | Chen XiaopingOTHER | 0 | Mar 15, 2024 | clinicaltrials |
| NCT04931615 | ARTISS a Single-centre Randomised Control Study(ARTISS) | completed | Phase 4 | 135 | Mid and South Essex NHS Foundation TrustOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06300099 | Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block | unknown | Phase 4 | 126 | Al-Azhar UniversityOTHER | 0 | Mar 12, 2024 | clinicaltrials |
| NCT04904653 | The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage | unknown | Phase 4 | 118 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05124002 | Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 66 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT03051516 | HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions | terminated | Phase 4 | 188 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06031493 | A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)(PROVIDENCE) | unknown | Phase 4 | 122 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06041425 | The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE | completed | Phase 4 | 40 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06217185 | The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). | recruiting | Phase 4 | 100 | Hebei Medical University Fourth HospitalOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06258486 | Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks | unknown | Phase 4 | 100 | Kaiser PermanenteOTHER | 0 | Feb 26, 2024 | clinicaltrials |
| NCT06276933 | A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | not yet recruiting | Phase 4 | 104 | Tongji UniversityOTHER | 0 | Feb 26, 2024 | clinicaltrials |
| NCT05949333 | Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy(NEUTHREE) | unknown | Phase 4 | 100 | Eunseong Medical Foundation Good GANG-AN HOSPITALOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT01673334 | Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms | completed | Phase 4 | 40 | University of VirginiaOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT06269445 | The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer | unknown | Phase 4 | 20 | Sir Run Run Shaw HospitalOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | completed | Phase 4 | 57 | Novartis PharmaceuticalsINDUSTRY | 16 | Feb 8, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 21, 2024source: clinicaltrials